All 266 IBB Holdings
The IBB ETF, or iShares Nasdaq Biotechnology ETF, is an investment product that allows you to invest in a diverse range of companies within the biotechnology sector. Biotechnology involves the use of living organisms or their components to create new products, such as medicines and therapies for various diseases. The ETF aims to track the performance of the Nasdaq Biotechnology Index, which consists of leading biotech companies listed on the Nasdaq Stock Market.
**Charts show 1 year
Rank | Ticker | Company | Weight | Country | Market Cap | Industry |
---|---|---|---|---|---|---|
1 | VRTX | Vertex Pharmaceuticals Inc | 9.9% | United States | $85b | Biotechnology |
2 | REGN | Regeneron Pharmaceuticals Inc | 8.94% | United States | $85b | Biotechnology |
3 | AMGN | Amgen Inc | 8.82% | United States | $131b | Drug Manufacturers-General |
4 | GILD | Gilead Sciences Inc | 8.12% | United States | $107b | Drug Manufacturers-General |
5 | IQV | IQVIA Holdings Inc | 4.15% | United States | $36b | Diagnostics & Research |
6 | SGEN | Seagen Inc | 4.03% | United States | $38b | Biotechnology |
7 | MRNA | Moderna Inc | 3.41% | United States | $52b | Biotechnology |
8 | BIIB | Biogen Inc | 2.72% | United States | $41b | Drug Manufacturers-General |
9 | MTD | Mettler-Toledo International Inc | 2.58% | United States | $33b | Diagnostics & Research |
10 | ILMN | Illumina Inc | 1.83% | United States | $35b | Diagnostics & Research |
11 | WAT | Waters Corporation | 1.73% | United States | $17.25b | Diagnostics & Research |
12 | ALNY | Alnylam Pharmaceuticals Inc | 1.69% | United States | $25b | Biotechnology |
13 | BNTX | BioNTech SE | 1.61% | United States | $28b | Biotechnology |
14 | BMRN | Biomarin Pharmaceutical Inc | 1.58% | United States | $17.83b | Biotechnology |
15 | ARGX | argenx NV ADR | 1.53% | United States | $22b | Biotechnology |
16 | GMAB | Genmab AS | 1.44% | United States | $27b | Biotechnology |
17 | NBIX | Neurocrine Biosciences Inc | 1.21% | United States | $9.89b | Drug Manufacturers-Specialty & Generic |
18 | IMCR | Immunocore Holdings Ltd | 1.19% | United States | $2.92b | Biotechnology |
19 | CRL | Charles River Laboratories | 1.13% | United States | $9.56b | Diagnostics & Research |
20 | INCY | Incyte Corporation | 1.11% | United States | $16.40b | Biotechnology |
21 | BGNE | BeiGene Ltd | 1.02% | United States | $26b | Biotechnology |
22 | UTHR | United Therapeutics Corporation | 1.01% | United States | $10.48b | Biotechnology |
23 | SRPT | Sarepta Therapeutics Inc | 0.94% | United States | $10.85b | Biotechnology |
24 | MEDP | Medpace Holdings Inc | 0.92% | United States | $6.47b | Diagnostics & Research |
25 | RGEN | Repligen Corporation | 0.79% | United States | $8.31b | Medical Instruments & Supplies |
26 | KRTX | Karuna Therapeutics Inc | 0.78% | United States | $6.78b | Biotechnology |
27 | BRKR | Bruker Corporation | 0.76% | United States | $11.29b | Medical Devices |
28 | NTRA | Natera Inc | 0.75% | United States | $5.74b | Diagnostics & Research |
29 | EXEL | Exelixis Inc | 0.7% | United States | $6.11b | Biotechnology |
30 | IMGN | ImmunoGen Inc | 0.66% | United States | $931.31m | Biotechnology |
31 | ITCI | Intracellular Th | 0.62% | United States | $5.79b | Drug Manufacturers-Specialty & Generic |
32 | ASND | Ascendis Pharma AS | 0.59% | United States | $4.48b | Biotechnology |
33 | LEGN | Legend Biotech Corp | 0.57% | United States | $11.48b | Biotechnology |
33 | RXDX | Prometheus Biosciences Inc | 0.57% | United States | $9.23b | Biotechnology |
35 | CYTK | Cytokinetics Inc | 0.56% | United States | $3.60b | Biotechnology |
36 | IONS | Ionis Pharmaceuticals Inc | 0.55% | United States | $5.13b | Biotechnology |
37 | VRNA | Verona Pharma PLC ADR | 0.51% | United States | $1.78b | Biotechnology |
37 | BPMC | Blueprint Medicines Corp | 0.51% | United States | $2.93b | Biotechnology |
37 | HALO | Halozyme Therapeutics Inc | 0.51% | United States | $4.54b | Biotechnology |
40 | RETA | Reata Pharmaceuticals Inc | 0.48% | United States | $3.20b | Biotechnology |
41 | APLS | Apellis Pharmaceuticals Inc | 0.42% | United States | $9.73b | Biotechnology |
41 | SYNH | INC Research Holdings Inc | 0.42% | United States | $3.92b | Diagnostics & Research |
43 | ISEE | IVERIC bio Inc | 0.41% | United States | $4.24b | Biotechnology |
44 | CRSP | Crispr Therapeutics AG | 0.39% | United States | $3.89b | Biotechnology |
45 | ALKS | Alkermes Plc | 0.38% | United States | $5.02b | Drug Manufacturers-Specialty & Generic |
46 | INSM | Insmed Inc | 0.31% | United States | $2.57b | Biotechnology |
47 | KRYS | Krystal Biotech Inc | 0.3% | United States | $2.25b | Biotechnology |
48 | FOLD | Amicus Therapeutics Inc | 0.29% | United States | $3.27b | Biotechnology |
48 | MRTX | Mirati Ther | 0.29% | United States | $2.51b | Biotechnology |
50 | RARE | Ultragenyx | 0.28% | United States | $2.94b | Biotechnology |